Your search matched 73 results
A recent survey by the Decision Resource Group reveals that only 34% of physicians feel that pharmaceutical websites are trustworthy.
In many ways, our innovation practice is grounded in the concept of constant change.
Mary Meeker's 2017 Internet Trends presentation captured new insights into dozens of digital advancements in healthcare
Lilly & Harvard Pilgrim Healthcare's CEOs shared their thoughts on value-based arrangements between pharma and payers
Last month, the nation’s largest physician-owned malpractice insurer published results from a major survey focused on the attitudes, beliefs and behaviors of doctors today—and the results were sobering.
With worldwide buzz being created by the 2016 Olympics in Rio, it would be easy to assume that Brazil’s biggest miracle in recent memory must involve an Olympian.
A few weeks back, five colleagues and I attended the 16th annual eyeforpharma conference in Philadelphia.
Live from EFP ‘18: In his presentation “From ‘Data-as-Assets’ to ‘Insights-as-Assets,’” GSK’s VP of Commercial Insights Peter Barschdorff shared a hit list of wisdom in the space.
The next time you see your busy doctor scratching her head in the office, there’s a good chance you might catch her consulting a colleague: Dr.
Toronto-based innovation shop Trend Hunter has cranked out over 10,000 custom trends profiles in the past decade, and today they’ve compressed their annual 3-day innovation experience and taken their show on the road with an 8-hour intensive course.
Recently, GSK and 23andMe announced a four-year collaboration aimed at identifying new drug targets, better supporting specific subpopulations and accelerating clinical progress.
eMarketer’s latest numbers on Pharma’s digital ad spend are in, and the word of the day is growth.
As you lie in the stiff hospital bed, you notice that it’s 3AM.
The World Health Organization estimates that around half of all medications aren’t taken as directed.
A recent survey commissioned by Google brings out powerful insights into the YouTube habits of a key demographic for many pharma brands: Generation X.
Study results published in the American Heart Association’s journal Stroke reveal that using AiCure’s AI-powered mobile app doubled anticoagulant adherence rates for stroke survivors.
Last week, pharmaceutical giant Sanofi and healthcare software pioneer Voluntis announced an expansion of their partnership focused on delivering digital therapy in the form of cutting-edge insulin titration tools.
On January 26th, MIT spinoff Empatica received FDA clearance for its epilepsy-tracking Embrace Watch — making it the first smartwatch approved in neurology in the US.
MM&M recently shared a series of infographics to visualize their top healthcare trends for 2018.
Before this year’s 16th annual eyeforpharma convention even officially began, Amazon was there, empowering pharma leaders by teaching them new ways from their approach to innovation.
Font for Forgetful Folks | Blog
In recent weeks, a group of researchers, behavioral scientists and typographic design specialists from down under have given the world an unforgettable new tool: a new font called Sans Forgetica.
A few weeks back, the digital healthcare company Optra Health announced the launch of OptraGURU, its newest platform that leverages the AI tech of its iPhronesis offering with Amazon Alexa’s natural language skills.
AI Saves Lives | Blog
Flying in the face of Sarah Connor and Elon Musk’s worst fears, artificial intelligence is saving lives worldwide.
In recent weeks, Amazon and Arcadia Group announced the launch of a series of consumer-grade medical devices under their new brand Choice.
Algorithms Unleashed | Blog
Live from EFP ‘18: Bharat Tewarie, EVP & Chief Marketing Officer at UCB shared his perspective on AI’s evolving role in pharma.
Live from EFP ‘18: Today, eyeforpharma Philadelphia opened with one word: trust.
Stressed About Your Diet? | Blog
For those of us squarely in the mid-latitudes of the northern hemisphere, fall is upon us, and that means more than PSLs to our Innovation team—trendspotting season is well underway.
Betting Big on Cancer.com | Blog
This month, Janssen launched Cancer.com, aiming to create an online destination for all things oncology.
While general diabetes incidence is declining in the US, several populations aren’t seeing the same progress.
Live from eyeforpharma Philadelphia 2019— eyeforpharma Chairperson Paul Simms kicked off today’s conference with 5 bold predictions for our industry.